Evidence map›Paper›PMID 28920074›Full record

ArticleAIMS molecular science2016

The mitotic checkpoint complex (MCC): looking back and forth after 15 years.

Song-Tao Liu, Hang Zhang

Abstract read
In one paragraph

Article in AIMS molecular science, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. CDC20: a novel therapeutic target in cancer.American journal of translational research · 2023
    Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Cell cycle control in cancer.Nature reviews. Molecular cell biology · 2022
    Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Song-Tao LiuDepartment of Biological Sciences, University of Toledo, 2801 West Bancroft St., Toledo, OH 43606, USA.
Hang ZhangDepartment of Biological Sciences, University of Toledo, 2801 West Bancroft St., Toledo, OH 43606, USA.

Funding

TRIP13 AAA-ATPase overexpression in chromosomal instability and breast cancerR01CA169500 · NCI · UNIVERSITY OF TOLEDO · PI LIU, SONG-TAO · 2014 to 2017
$1.4M
NCI NIH HHS R01 CA169500
6 · The paper itself

Abstract

The mitotic checkpoint is a specialized signal transduction pathway that contributes to the fidelity of chromosome segregation. The signaling of the checkpoint originates from defective kinetochore-microtubule interactions and leads to formation of the mitotic checkpoint complex (MCC), a highly potent inhibitor of the Anaphase Promoting Complex/Cyclosome (APC/C)-the E3 ubiquitin ligase essential for anaphase onset. Many important questions concerning the MCC and its interaction with APC/C have been intensively investigated and debated in the past 15 years, such as the exact composition of the MCC, how it is assembled during a cell cycle, how it inhibits APC/C, and how the MCC is disassembled to allow APC/C activation. These efforts have culminated in recently reported structure models for human MCC:APC/C supra-complexes at near-atomic resolution that shed light on multiple aspects of the mitotic checkpoint mechanisms. However, confusing statements regarding the MCC are still scattered in the literature, making it difficult for students and scientists alike to obtain a clear picture of MCC composition, structure, function and dynamics. This review will comb through some of the most popular concepts or misconceptions about the MCC, discuss our current understandings, present a synthesized model on regulation of CDC20 ubiquitination, and suggest a few future endeavors and cautions for next phase of MCC research.

Indexed as

anaphase promoting complex/cyclosomeBUBR1CDC20chromosome segregationMAD2mitotic checkpointmitotic checkpoint complexubiquitin ligase

Identifiers

PMID28920074
PMCPMC5597056

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.